99 related articles for article (PubMed ID: 22200423)
1. Cellular toxicity of nicotinamide metabolites.
Rutkowski B; Rutkowski P; Słomińska E; Smolenski RT; Swierczyński J
J Ren Nutr; 2012 Jan; 22(1):95-7. PubMed ID: 22200423
[TBL] [Abstract][Full Text] [Related]
2. Distribution of purine nucleotides in uremic fluids and tissues.
Rutkowski B; Rutkowski P; Słomińska E; Swierczyński J
J Ren Nutr; 2010 Sep; 20(5 Suppl):S7-10. PubMed ID: 20797575
[TBL] [Abstract][Full Text] [Related]
3. A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate.
Slominska EM; Carrey EA; Foks H; Orlewska C; Wieczerzak E; Sowinski P; Yacoub MH; Marinaki AM; Simmonds HA; Smolenski RT
J Biol Chem; 2006 Oct; 281(43):32057-64. PubMed ID: 16920716
[TBL] [Abstract][Full Text] [Related]
4. 4-Pyridone-3-carboxamide-1β-D-ribonucleoside metabolism in endothelial cells and its impact on cellular energetic balance.
Pelikant-Małecka I; Sielicka A; Kaniewska E; Smoleński RT; Słomińska EM
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):338-41. PubMed ID: 24940690
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of 4-pyridone-3-carboxamide-1β-d-ribonucleoside (4PYR) in primary murine brain microvascular endothelial cells (mBMECs).
Pelikant-Małecka I; Smoleński RT; Słomińska EM
Nucleosides Nucleotides Nucleic Acids; 2018; 37(11):639-644. PubMed ID: 30663501
[TBL] [Abstract][Full Text] [Related]
6. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?
Synesiou E; Fairbanks LD; Simmonds HA; Slominska EM; Smolenski RT; Carrey EA
Toxins (Basel); 2011 Jun; 3(6):520-37. PubMed ID: 22069723
[TBL] [Abstract][Full Text] [Related]
7. In vitro and cellular effects of 4-pyridone-3-carboxamide riboside on enzymes of nucleotide metabolism.
Slominska EM; Borkowski T; Rybakowska I; Abramowicz-Glinka M; Orlewska C; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):353-7. PubMed ID: 24940693
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate and its nucleoside precursor in the erythrocytes.
Slominska EM; Orlewska C; Yuen A; Osman L; Romaszko P; Sokolowska E; Foks H; Simmonds HA; Yacoub MH; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):830-4. PubMed ID: 18600548
[TBL] [Abstract][Full Text] [Related]
9. Influence of 4-pyridone-3-carboxamide-1Β-D-ribonucleoside (4PYR) on activities of extracellular enzymes in endothelial human cells.
Pelikant-Małecka I; Sielicka A; Kaniewska E; Smoleński RT; Słomińska EM
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):732-736. PubMed ID: 27906624
[TBL] [Abstract][Full Text] [Related]
10. Effect of 4-pyridone-3-carboxamide ribonucleoside (4PYR)-potential cardiovascular toxin in perfused rat heart.
Romaszko P; Slominska EM; Smolenski RT
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):333-7. PubMed ID: 24940689
[TBL] [Abstract][Full Text] [Related]
11. 4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism.
Laurence A; Edbury SM; Marinaki AM; Smolenski RT; Goldsmith DJ; Simmonds HA; Carrey EA
Clin Exp Med; 2007 Dec; 7(4):135-41. PubMed ID: 18188525
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma concentration of 4-pyridone-3-carboxamide-1-ß-D-ribonucleoside (4PYR) in lung cancer. Preliminary studies.
Jablonska P; Mierzejewska P; Kutryb-Zajac B; Rzyman W; Dziadziuszko R; Polanska J; Sitkiewicz M; Smolenski RT; Slominska EM
Nucleosides Nucleotides Nucleic Acids; 2019; 38(10):781-787. PubMed ID: 30990116
[TBL] [Abstract][Full Text] [Related]
13. Endothelial toxicity of unusual nucleotide metabolites.
Pelikant-Malecka I; Sielicka A; Kaniewska E; Smolenski RT; Slominska EM
Pharmacol Rep; 2015 Aug; 67(4):818-22. PubMed ID: 26321286
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of 4-pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) in rodent tissues and in vivo.
Romaszko P; Slominska EM; Orlewska C; Lipinski M; Smolenski RT
Mol Cell Biochem; 2011 May; 351(1-2):143-8. PubMed ID: 21312056
[TBL] [Abstract][Full Text] [Related]
15. The novel nucleotide 4KNTP, in high concentrations in erythrocytes of renal failure children: a comparison with accumulation of other putative precursors in the plasma.
Carrey EA; Synesiou E; Simmonds HA; Fairbanks LD
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1051-4. PubMed ID: 17065063
[TBL] [Abstract][Full Text] [Related]
16. Metabolic pathway of 4-pyridone-3-carboxamide-1β-d-ribonucleoside and its effects on cellular energetics.
Pelikant-Malecka I; Kaniewska-Bednarczuk E; Szrok S; Sielicka A; Sledzinski M; Orlewska C; Smolenski RT; Slominska EM
Int J Biochem Cell Biol; 2017 Jul; 88():31-43. PubMed ID: 28323211
[TBL] [Abstract][Full Text] [Related]
17. Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.
Jedrzejewska A; Jablonska P; Gawlik-Jakubczak T; Czajkowski M; Maszka P; Mierzejewska P; Smolenski RT; Slominska EM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397036
[TBL] [Abstract][Full Text] [Related]
18. Relationship between uremic toxins and oxidative stress in patients with chronic renal failure.
Rutkowski P; Słominska EM; Szołkiewicz M; Aleksandrowicz E; Smolenski RT; Wołyniec W; Renke M; Wisterowicz K; Swierczynski J; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):243-8. PubMed ID: 17469035
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
